We are live on
!
Find out more
Matinas BioPharma
MTNB
MTNB
28 hedge funds and large institutions have $177K invested in Matinas BioPharma in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
1.38% less ownership
Funds ownership: 6.91% → 5.53% (-1.4%)
7% less funds holding
Funds holding: 30 → 28 (-2)
32% less capital invested
Capital invested by funds: $260K → $177K (-$83K)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
-$27.2K |
| 2 |
Jane Street
New York
|
-$9.32K |
| 3 |
VF
Virtu Financial
New York
|
-$9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.79K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.25K |
